Beyond the White Pill: Advocating for Racial Diversity in IBD Trials Journal Articles

abstract

• AbstractAlthough inflammatory bowel disease [IBD] affects an increasingly diverse patient population, most patients in IBD clinical trials are White. Acknowledging current barriers and taking meaningful action is required at multiple levels to improve racial diversity across clinical trials in IBD. Ultimately, improving racial diversity in trials can in turn improve the care received by the diverse patients seen in clinical practice.

authors

• Wong, Emily CL
• Moayyedi, Paul
• Narula, Neeraj

status

• published 

publication date

• April 3, 2023

has subject area

• 1103 Clinical Sciences (FoR)
• Gastroenterology & Hepatology (Science Metrix)
• Humans (MeSH)
• Inflammatory Bowel Diseases (MeSH)
• Racial Groups (MeSH)

published in

• Journal of Crohn's and Colitis  Journal

keywords

• Humans
• Inflammatory Bowel Diseases
• Inflammatory bowel disease
• Racial Groups
• clinical trials
• disparities
• race

Digital Object Identifier (DOI)

• 10.1093/ecco-jcc/jjac134

PubMed ID

• 36087074

start page

• 459

end page

• 461

volume

• 17

issue

• 3